Scientific Sessions 2025  /  TCT at AHA: Renal Denervation for Hypertension: What Comes Next?  /  Alternative Renal Denervation Devices – From Ablative Solutions to Verve
Logo

American Heart Association

  43
  0

Final ID:

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

  • Kandzari, David  ( Piedmont Heart Institute , Atlanta , Georgia , United States )
  • Kirtane, Ajay  ( Columbia University Medical Center , New York , New York , United States )
  • Mahfoud, Felix  ( University Hospital Basel , Basel , Switzerland )
    • Author Disclosures:
    David Kandzari: No Answer | Ajay Kirtane: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):See Concur Disccosures (Several):Active (exists now) | Felix Mahfoud: DO have relevant financial relationships ; Consultant:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed) ; Speaker:Ablative Solutions, Astra-Zeneca, Inari, Medtronic, Merck, Novartis, Philips and ReCor Medical.:Past (completed) ; Researcher:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Renal Denervation for Hypertension: What Comes Next?

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Bhatt Deepak

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Secemsky Eric, Krawisz Anna

More abstracts from these authors:
Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Mahfoud Felix

National Estimates of Patient Eligibility for Renal Denervation Therapy Post-FDA Approval

Watson Nathan, Earle William, Kandzari David, Kirtane Ajay, Mahfoud Felix, Cluett Jennifer, Krawisz Anna, Juraschek Stephen, Secemsky Eric

You have to be authorized to contact abstract author. Please, Login
Not Available